0001415889-24-008643.txt : 20240319 0001415889-24-008643.hdr.sgml : 20240319 20240319190744 ACCESSION NUMBER: 0001415889-24-008643 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240318 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cooper Simon Peter CENTRAL INDEX KEY: 0001877225 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38940 FILM NUMBER: 24765694 MAIL ADDRESS: STREET 1: C/O KEROS THERAPEUTICS, INC. STREET 2: 99 HAYDEN AVE., BUILDING E, SUITE 120 CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Morphic Holding, Inc. CENTRAL INDEX KEY: 0001679363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473878772 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 996-0955 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Morphic Holding, LLC DATE OF NAME CHANGE: 20160712 4 1 form4-03192024_110335.xml X0508 4 2024-03-18 0001679363 Morphic Holding, Inc. MORF 0001877225 Cooper Simon Peter C/O MORPHIC HOLDING, INC. 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 false true false false CMO 0 Employee Stock Options (right to buy) 33.46 2024-03-18 4 A 0 170000 0 A Common Stock 170000 170000 D Restricted Stock Unit 2024-03-18 4 A 0 14000 0 A Common Stock 14000 14000 D Restricted Stock Unit 2024-03-18 4 A 0 7000 0 A Common Stock 7000 7000 D The option vests as to 25% of the total shares on March 18, 2025, and then 2.0833% of the remaining shares shall vest monthly thereafter, subject to the reporting person's provision of service to the issuer on each vesting date. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. The RSUs vest as to 25% of the total shares on each of March 18, 2025, March 18, 2026, March 18, 2027 and March 18, 2028, subject to the reporting person's provision of service to the issuer on each vesting date. The RSUs vest as to 50% of the total shares on March 18, 2025 and 50% of the total shares on September 18, 2025, subject to the reporting person's provision of service to the issuer on each vesting date. /s/ Robert Farrell, as attorney-in-fact for Simon Cooper 2024-03-19